Anti-TNF agents linked to shingles risk with rheumatoid arthritis

01/10/2013 | MedPage Today (free registration)

Rheumatoid arthritis patients who took anti-tumor necrosis factor drugs such as etanercept, infliximab and adalimumab had a significantly greater risk of developing shingles than those on disease-modifying antirheumatic drugs, according to a study of more than 15,000 patients in the U.K. The findings appeared in the journal Annals of the Rheumatic Diseases.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY